Solaraze 3% gel United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

solaraze 3% gel

almirall ltd - diclofenac sodium - cutaneous gel - 30mg/1gram

Actikerall-Almirall 5mg/g + 100mg/g Lösung zur Anwendung auf der Haut Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

actikerall-almirall 5mg/g + 100mg/g lösung zur anwendung auf der haut

Solaraze 3% gel Ireland - English - HPRA (Health Products Regulatory Authority)

solaraze 3% gel

almirall, s.a. - diclofenac sodium - gel - 3 percent - diclofenac

Vaniqa European Union - English - EMA (European Medicines Agency)

vaniqa

almirall, s.a. - eflornithine - hirsutism - other dermatological preparations - treatment of facial hirsutism in women.

Vaniqa 11.5% cream United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vaniqa 11.5% cream

almirall ltd - eflornithine monohydrate chloride - cream - 115mg/1gram

Skilarence 120mg gastro-resistant tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

skilarence 120mg gastro-resistant tablets

almirall ltd - dimethyl fumarate - gastro-resistant tablet - 120mg

Skilarence 30mg gastro-resistant tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

skilarence 30mg gastro-resistant tablets

almirall ltd - dimethyl fumarate - gastro-resistant tablet - 30mg

Curatoderm 4 µg/g ointm. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

curatoderm 4 µg/g ointm.

almirall hermal gmbh - tacalcitol monohydrate 4,17 µg/g - eq. tacalcitol 4 µg/g - ointment - 4 µg - g - tacalcitol monohydrate - tacalcitol

Curatoderm 4 µg/g cut. emuls. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

curatoderm 4 µg/g cut. emuls.

almirall hermal gmbh - tacalcitol monohydrate 4,17 µg/g - eq. tacalcitol 4 µg/g - cutaneous emulsion - 4 µg - g - tacalcitol monohydrate - tacalcitol

Klisyri European Union - English - EMA (European Medicines Agency)

klisyri

almirall, s.a. - tirbanibulin - keratosis, actinic - antibiotics and chemotherapeutics for dermatological use - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.